¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"National Cholesterol Education Program"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • medical self help program
    ÀÇ·áÀÚ°¡ÇÁ·Î±×·¥
  • program
    °èȹ, »ç¾÷, ÇÁ·Î±×·¥
  • quality assurance program
    Áúº¸Áõ°èȹ
  • quality control program
    Áú°ü¸®ÇÁ·Î±×·¥
  • regional program
    Áö¿ªÇÁ·Î±×·¥
  • regional quality control program
    Áö¿ªÁú°ü¸®ÇÁ·Î±×·¥
  • school health program
    Çб³º¸°Ç»ç¾÷
  • school lunch program
    Çб³±Þ½Ä»ç¾÷
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • self-designed program
    ÀÚ°¡±¸»óÇÁ·Î±×·¥
  • short-term inpatient program
    ´Ü±âÀÔ¿øÈ¯ÀÚÇÁ·Î±×·¥
  • weight control program
    üÁßÁ¶Àý°èȹ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • quality control program
    Áú°ü¸®°èȹ
  • regional program
    Áö¿ªÇÁ·Î±×·¥
  • regional quality control program
    Áö¿ªÁú°ü¸®ÇÁ·Î±×·¥
  • school health program
    Çб³º¸°Ç»ç¾÷
  • school lunch program
    Çб³±Þ½Ä»ç¾÷
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • short-term inpatient program
    ´Ü±âÀÔ¿øÈ¯ÀÚÇÁ·Î±×·¥
  • weight control program
    üÁßÁ¶Àý°èȹ
  • self-designed program
    ÀÚ°¡±¸»óÇÁ·Î±×·¥
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • physical education
    üÀ°±³À°.
  • professional education
    Á÷¾÷±³À°(ÊÙË´Ëô).
  • psychiatric education
    Á¤½ÅÀÇÇб³À°, Á¤½Å°úÇб³À°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cholesterol
    ÄÝ·¹½ºÅ×·Ñ
  • cholesterol esterase
    ÄÝ·¹½ºÅ×·Ñ ¿¡½ºÅ×¶óÁ¦
  • cholesterol granuloma
    ÄÝ·¹½ºÅ×·Ñ À°¾ÆÁ¾
  • cholesterol measurement
    ÄÝ·¹½ºÅ×·Ñ ÃøÁ¤
  • cholesterol pericarditis
    ÄÝ·¹½ºÅ׷ѽɳ¶¿°.
  • gallstone,cholesterol
    ÄÝ·¹½ºÅ×·Ñ
  • glycerol cholesterol test
    ±Û¸®¼¼¸°ÄÝ·¹½ºÅ׷ѽÃÇè.
  • granuloma, cholesterol
    ÄÝ·¹½ºÅ×·Ñ À°¾ÆÁ¾
  • lecithin cholesterol acyltransferase LCAT
    ·¹½Ãƾ ÄÝ·¹½ºÅ×·Ñ ¾Æ½ÇÆ®¶õ½ºÆÛ·¹À̽º.
  • low cholesterol diet
    ÀúÄÝ·¹½ºÅ×·Ñ½Ä (­ãÝ).
  • behavior monitoring program
    Çൿ(ÇàÅÂ)°¨½ÃÇÁ·Î±×·¥
  • cancer control program
    ¾Ï°ü¸®°èȹ(ËâË´ËöË­Ì·), ¾Ï¿¹¹æ»ç¾÷.
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷.
  • committee on in service program
    ½Ç¹«±³À°À§¿øÈ¸(ËàËÎË´ËôËôËôÌ·).
  • committee on in service program
    ½Ç¹«±³À°À§¿øÈ¸(ãùÙâÎçëÀêÍê¬üå).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CE California encephalitis; cardiac enlargement; cardioesophageal; carotid endarterectomy; catamenial e...
NPA-NIHHDP National Pituitary Agency-National Institutes of Health Hormone Distribution Program
CME cervical mediastinal exploration; continuing medical education; Council on Medical Education; crude ...
DNE Director of Nursing Education; Doctor of Nursing Education
CEARP Continuing Education Approval and Recognition Program
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NTP National Toxicology Program
HDL cholesterol High density lipoprotein cholesterol
LDL-cholesterol Low-density-lipoprotein cholesterol
LDL-C lipoprotein cholesterol and low-density lipoprotein cholesterol
ACGME Accreditation Council for Graduate Medical Education
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • home health education
    °¡Á¤ º¸°Ç ±³À°
  • in service education
    ½Ç¹« ±³À°
  • medical education
    ÀÇÇÐ ±³À°
  • muscle re-education
    ±Ù Àç±³À°, ±ÙÀ° ÈÆ·Ã
    ¼Ò¾Æ ¸¶ºñ, ±æ¶û¹Ù·¹ ÁõÈıº µîÀÇ ¸»ÃʽŰæ Àå¾Ö¿¡ µû¸¥ À̿ϼº ¸¶ºñ¿¡ ´ëÇØ¼­ ½ÃÇàµÇ´Â ¿îµ¿¿ä¹ýÀÇ ÀÏÁ¾ÀÌ´Ù. ±Ù ¼öÃàÀÌ °ÅÀÇ ÀÎÁ¤µÇÁö ¾Ê´Â °æ¿ì¿¡´Â ȯÀÚ¸¦ Ÿµ¿ÀûÀ¸·Î ¿òÁ÷¿©¼­ °íÀ¯ °¨°¢°è¸¦ ÀÚ±ØÇÔÀ¸·Î½á ±ÙÀÇ ¼öÃàÀ» ÃËÁø½ÃŰ·Á´Â °ÍÀÌ´Ù. ±Ù ¼öÃàÀÌ ³ªÅ¸³ª´Â °Í¿¡ µû¶ó¼­ ±Ù·Â Áõ°­ ÈÆ·ÃÀ¸·Î ÀÌ¿ëÇÑ´Ù.
  • physical education
    üÀ° ±³À°
  • safety education
    ¾ÈÀü ±³À°
    ¾ÈÀüÇÑ »ýȰÀ» ÇÒ ¼ö ÀÖµµ·Ï ÇÊ¿äÇÑ Áö½ÄÀ» ÁÖ´Â °Í.
  • active exercise program
    Àû±ØÀû ¿îµ¿
  • case finding program
    ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
  • counseling program
    »ó´ã¹ý
  • credencialing program
    ½ÅÀÓ °úÁ¤
  • dental health program
    ±¸°­ º¸°Ç »ç¾÷
    ±¸°­ °Ç°­À» ÁöÄѳª°¡±â À§ÇØ ¹ü ±¹¹ÎÀû ¶Ç´Â ¹ü Áö¿ªÀûÀ¸·Î ½Ç½ÃÇÏ´Â ÇÁ·Î±×·¥. ¿¹¸¦ µé¸é ¼öµ¾¹° ºÒ¼ÒÈ­ »ç¾÷ µîÀÌ ÀÖ´Ù.
  • health promotion program
    °Ç°­ Çâ»ó °èȹ
  • home program
    ÀÚ°¡ Ä¡·á °úÁ¤
  • postdoctoral program
    Á¹¾÷ ÈÄ °úÁ¤
  • predoctoral dental educational program
    Ä¡°ú ´ëÇÐ ±³°ú °úÁ¤
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
national health planning information centre A centre in the health resources administration division of planning methods and technology which provides access to current information on health planning and resources development.
(12 Dec 1998)
national health programs Components of a national health care system which administer specific services, e.g., national health insurance.
(12 Dec 1998)
national institute for occupational safety and health An institute of the centres for disease control and prevention which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals.
(12 Dec 1998)
national institute of mental health A component of the national institutes of health concerned with research, overall planning, promoting, and administering mental health programs and research.
(12 Dec 1998)
National Institutes of Health <organisation> A nonregulatory U.S. Federal agency which has oversight of research activities that the agency funds.
(09 Oct 1997)
national library of medicine An agency of the national institutes of health concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine.
(12 Dec 1998)
national practitioner data bank A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like.
(12 Dec 1998)
National Science Foundation <organisation> A nonregulatory U.S. Federal agency which has oversight of biotechnology research activities that the agency funds.
(09 Oct 1997)
united states national aeronautics and space administration An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles.
(12 Dec 1998)
los alamos national laboratory <radiobiology> Major DOE research facility, located in Los Alamos, new Mexico, about an hour west of Santa Fe. Former home of a frozen-deuterium-fibre Z-pinch device, which was dismantled. Home to an active theory division, including the Numerical Tokamak Grand Challenge (being performed on the CM-5 massively-parallel supercomputer). Also home to former alternative-concepts experimental devices like Scyllac, FRX-A, FRX-B, FRX-C/LSM, ZT40, and the aborted CPRF which was killed in 1991 when it was almost complete (budget cuts). Currently there are some small in-house experiments, including one on electrostatic confinement as a possible fusion device, and/or a compact neutron source. They also do theory and experimental collaboration with other labs worldwide.
(09 Oct 1997)
acid cholesterol ester synthetase <enzyme> Aortal enzyme, does not require exogenous ATP or CoA; reverse reaction of cholesterol esterase
Registry number: EC 3.1.1.-
Synonym: cholesterol ester synthetase
(26 Jun 1999)
good cholesterol High-density lipoprotein (HDL) cholesterol.
(12 Dec 1998)
cholesterol 1. <biochemistry> A pearly, fatlike steroid alcohol, C27H45OH, crystallizing in the form of leaflets or plates from dilute alcohol and found in animal fats and oils, in bile, blood, brain tissue, milk, yolk of egg, myelin sheaths of nerve fibres, the liver, kidneys and adrenal glands.
It constitutes a large part of the most frequently occurring type of gallstones and occurs in atheroma of the arteries, in various cysts and in carcinomatous tissue. Most of the bodys cholesterol is synthesised in the liver, but some is absorbed from the diet. It is a precursor of bile acids and is important in the synthesis of steroid hormones.
2. <chemical> A commercial preparation of cholesterol is used as a pharmaceutic aid.
Synonym: cholesterin.
Origin: Gr. Stereos = solid
(15 Jan 1998)
cholesterol 26-hydroxylase <enzyme> Cyt p-450 dependent, ferredoxin involved
Registry number: EC 1.14.15.-
(26 Jun 1999)
cholesterol-5 alpha,6 alpha-epoxide hydrase <enzyme> Aspect of epoxide hydrolase, EC 3.3.2.3
Pharmacological action: carcinogen
Registry number: EC 3.3.2.-
Synonym: cholesterol epoxide hydrase, cholesterol epoxide hydrolase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • program music
    Ç¥Á¦ À½¾Ç
  • program picture
    µ¿½Ã »ó¿µ ¿µÈ­
  • supporting program(me)
    º¸Á¶ ÇÁ·Î±×·¥;µ¿½Ã »ó¿µ ¿µÈ­
  • education
    ±³À°
  • education park
    ¹®±³ µµ½Ã
  • Gerneral Certificate of Education
    ÀÏ¹Ý ±³À° Áõ¼­;(ÀÌ Áõ¼­¸¦ ¾ò±â À§ÇÑ)ÀÏ¹Ý ±³À° À̼ö Áõ¸í ½ÃÇè
  • adult education
    ¼ºÀα³À°
  • career education
    Ä¿¸®¾î ±³À°(À¯Ä¡¿ø¿¡¼­ °í±³±îÁöÀÇ ÀϰüµÈ Áöµµ·Î ¾Ë¸ÂÀº Áø·á ¼±ÅÃÀ» µµ¸ðÇÏ·Á´Â ¹Ì±¹ÀÇ ±³À°Á¦µµ)
  • continuing education
    °è¼Ó ±³À°;¼ºÀÎ ±³À°(ÃֽŠÁö½Ä.±â´ÉÀ» °¡¸£Ä¡´Â)
  • death education
    Á×À½¿¡ °üÇÑ ±³À°(Á×À½ ¹× Á×À½¿¡ °üÇÑ ¹®Á¦µéÀ» ´Ù·ç´Â ±³À°)
  • distributive education
    Á÷¾÷ ½Ç½À ±³À°
  • education
    ±³À°;ÈÆµµ;¾çÀ°
  • education tax
    =EIPLOMA TAX
  • formal education
    Çü½ÄÀû(Á¤±Ô) ±³À°
  • further education
    ¼ºÀα³À°
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á